IL17A and pulmonary emphysema: In COPD patients, T cells in the peripheral airways exhibit an enhanced ability to express CXCR3 and IFN-γ (48), and increased IL-17A secretion from Th17 cells, along with its signature protein RORγt, is directly correlated with the severity of emphysema.